Media Coverage


March 2, 2018

Heidi Ledford of Nature highlights the modification of an enzyme that will allow for enhanced CRISPR-Cas9 gene editing, led by Broad Institute researcher David Liu. Ledford explains that while Liu believes the enzyme could be a staple in the lab, he also adds that “it will need more testing before its full potential becomes clear.”

Go to News Coverage

Other Coverage